Growth Metrics

Neogenomics (NEO) Capital Leases: 2009-2021

Historic Capital Leases for Neogenomics (NEO) over the last 12 years, with Dec 2021 value amounting to $71,000.

  • Neogenomics' Capital Leases fell 92.66% to $71,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $71,000, marking a year-over-year decrease of 92.66%. This contributed to the annual value of $71,000 for FY2021, which is 92.66% down from last year.
  • Latest data reveals that Neogenomics reported Capital Leases of $71,000 as of Q4 2021, which was down 53.29% from $152,000 recorded in Q3 2021.
  • Over the past 5 years, Neogenomics' Capital Leases peaked at $11.5 million during Q4 2018, and registered a low of $71,000 during Q4 2021.
  • Its 3-year average for Capital Leases is $2.1 million, with a median of $1.7 million in 2020.
  • Its Capital Leases has fluctuated over the past 5 years, first skyrocketed by 96.02% in 2017, then plummeted by 92.66% in 2021.
  • Quarterly analysis of 5 years shows Neogenomics' Capital Leases stood at $10.5 million in 2017, then rose by 9.54% to $11.5 million in 2018, then crashed by 72.30% to $3.2 million in 2019, then slumped by 69.77% to $967,000 in 2020, then slumped by 92.66% to $71,000 in 2021.
  • Its Capital Leases was $71,000 in Q4 2021, compared to $152,000 in Q3 2021 and $448,000 in Q2 2021.